Up next

Autoplay

Recent advances in eosinophilia with FGFR rearrangement

1 Views • 07/06/23
Share
Embed
administrator
administrator
Subscribers
0

Jean-Jacques Kiladjian, MD, PhD, Saint-Louis Hospital & Paris Diderot University, Paris, France, gives an update on the management of eosinophilia with fibroblast growth factor receptor (FGFR) rearrangement. Encouraging results from the FIGHT-203 study (NCT03011372) evaluating pemigatinib are expected to improve the outcomes of this patient population. This interview took place virtually.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay